PMC:7253482 / 2108-2310
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"67","span":{"begin":73,"end":78},"obj":"Gene"}],"attributes":[{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"Gene:43740568"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":83,"end":91},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":60,"end":65},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":83,"end":91},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T8","span":{"begin":13,"end":22},"obj":"http://purl.obolibrary.org/obo/IDO_0000528"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T321","span":{"begin":0,"end":6},"obj":"VB"},{"id":"T322","span":{"begin":7,"end":12},"obj":"DT"},{"id":"T323","span":{"begin":13,"end":22},"obj":"NNS"},{"id":"T324","span":{"begin":24,"end":31},"obj":"VBG"},{"id":"T325","span":{"begin":32,"end":39},"obj":"NN"},{"id":"T326","span":{"begin":40,"end":51},"obj":"NN"},{"id":"T327","span":{"begin":52,"end":59},"obj":"NNS"},{"id":"T328","span":{"begin":60,"end":65},"obj":"NN"},{"id":"T329","span":{"begin":66,"end":68},"obj":"IN"},{"id":"T330","span":{"begin":69,"end":72},"obj":"DT"},{"id":"T331","span":{"begin":73,"end":78},"obj":"NN"},{"id":"T332","span":{"begin":79,"end":80},"obj":"-LRB-"},{"id":"T333","span":{"begin":80,"end":81},"obj":"NN"},{"id":"T334","span":{"begin":81,"end":82},"obj":"-RRB-"},{"id":"T335","span":{"begin":83,"end":91},"obj":"NNS"},{"id":"T336","span":{"begin":92,"end":96},"obj":"WDT"},{"id":"T337","span":{"begin":97,"end":105},"obj":"VBP"},{"id":"T338","span":{"begin":106,"end":110},"obj":"IN"},{"id":"T339","span":{"begin":111,"end":114},"obj":"DT"},{"id":"T340","span":{"begin":115,"end":120},"obj":"JJ"},{"id":"T341","span":{"begin":121,"end":129},"obj":"NN"},{"id":"T342","span":{"begin":130,"end":133},"obj":"CC"},{"id":"T343","span":{"begin":134,"end":144},"obj":"VB"},{"id":"T344","span":{"begin":145,"end":148},"obj":"DT"},{"id":"T345","span":{"begin":149,"end":153},"obj":"JJ"},{"id":"T346","span":{"begin":154,"end":160},"obj":"NN"},{"id":"T347","span":{"begin":161,"end":163},"obj":"IN"},{"id":"T348","span":{"begin":164,"end":176},"obj":"VBG"},{"id":"T349","span":{"begin":177,"end":190},"obj":"NN"},{"id":"T350","span":{"begin":192,"end":197},"obj":"DT"}],"relations":[{"id":"R318","pred":"arg2Of","subj":"T323","obj":"T321"},{"id":"R319","pred":"arg1Of","subj":"T323","obj":"T322"},{"id":"R320","pred":"arg1Of","subj":"T328","obj":"T324"},{"id":"R321","pred":"arg1Of","subj":"T328","obj":"T325"},{"id":"R322","pred":"arg1Of","subj":"T328","obj":"T326"},{"id":"R323","pred":"arg1Of","subj":"T328","obj":"T327"},{"id":"R324","pred":"arg1Of","subj":"T328","obj":"T329"},{"id":"R325","pred":"arg2Of","subj":"T335","obj":"T329"},{"id":"R326","pred":"arg1Of","subj":"T335","obj":"T330"},{"id":"R327","pred":"arg1Of","subj":"T335","obj":"T331"},{"id":"R328","pred":"arg1Of","subj":"T335","obj":"T332"},{"id":"R329","pred":"arg2Of","subj":"T333","obj":"T332"},{"id":"R330","pred":"arg3Of","subj":"T334","obj":"T332"},{"id":"R331","pred":"arg1Of","subj":"T335","obj":"T336"},{"id":"R332","pred":"arg1Of","subj":"T335","obj":"T337"},{"id":"R333","pred":"arg1Of","subj":"T337","obj":"T338"},{"id":"R334","pred":"arg2Of","subj":"T341","obj":"T338"},{"id":"R335","pred":"arg1Of","subj":"T341","obj":"T339"},{"id":"R336","pred":"arg1Of","subj":"T341","obj":"T340"},{"id":"R337","pred":"arg1Of","subj":"T337","obj":"T342"},{"id":"R338","pred":"arg2Of","subj":"T343","obj":"T342"},{"id":"R339","pred":"arg1Of","subj":"T335","obj":"T343"},{"id":"R340","pred":"arg2Of","subj":"T346","obj":"T343"},{"id":"R341","pred":"arg1Of","subj":"T346","obj":"T344"},{"id":"R342","pred":"arg1Of","subj":"T346","obj":"T345"},{"id":"R343","pred":"arg1Of","subj":"T346","obj":"T347"},{"id":"R344","pred":"arg2Of","subj":"T348","obj":"T347"},{"id":"R345","pred":"arg2Of","subj":"T349","obj":"T348"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T10","span":{"begin":83,"end":91},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T10","span":{"begin":83,"end":91},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T15","span":{"begin":24,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"67","span":{"begin":73,"end":78},"obj":"Gene"}],"attributes":[{"id":"A67","pred":"pubann:denotes","subj":"67","obj":"Gene:43740568"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T714","span":{"begin":79,"end":91},"obj":"Protein"}],"attributes":[{"id":"A714","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIP0"},{"id":"A715","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN9"},{"id":"A716","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN8"},{"id":"A717","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN7"},{"id":"A718","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN6"},{"id":"A719","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UBH8"},{"id":"A720","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH8"},{"id":"A721","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH7"},{"id":"A722","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH6"},{"id":"A723","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH5"},{"id":"A724","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH4"},{"id":"A725","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NPG5"},{"id":"A726","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NPE0"},{"id":"A727","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NP52"},{"id":"A728","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q95IF9"},{"id":"A729","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8N5P3"},{"id":"A730","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8IZU6"},{"id":"A731","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8IZU5"},{"id":"A732","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8IZU4"},{"id":"A733","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q86Z04"},{"id":"A734","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q7YR44"},{"id":"A735","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q7LA71"},{"id":"A736","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q7LA70"},{"id":"A737","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q5STD2"},{"id":"A738","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q5SQ85"},{"id":"A739","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q1XI16"},{"id":"A740","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q1XI12"},{"id":"A741","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q15517"},{"id":"A742","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/O43509"},{"id":"A743","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/O19084"},{"id":"A744","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/B0UYZ7"},{"id":"A745","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/B0S7V2"},{"id":"A746","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/A5A6L9"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":24,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trim"}